The novel therapy of the medication represents a significant advance in the care of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide affects multiple pathways – GLP-1 and GIP – leading to https://tirzepatidepeptide789231.blogrelation.com/48670818/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment